Access Toxo IgG— 510(k) K242022

Substantially Equivalent

Beckman Coulter, Inc.

FDA 510(k) clearance K242022 for Access Toxo IgG, Substantially Equivalent on 2025-03-28. Applicant: Beckman Coulter, Inc..

Clearance details

Applicant: Beckman Coulter, Inc.
Product code: Code LGD
Advisory panel: Microbiology
Date received: 2024-07-11
Decision date: 2025-03-28
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Chaska, MN, US

Download summary PDF View on FDA.gov ↗

Adverse events under product code LGD

product code LGD

Malfunction: 502
Total: 502

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.